Actively Recruiting
The NaBu Effect on Menstruation in Women
Led by Magdy Milad, MD · Updated on 2026-04-29
15
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.
CONDITIONS
Official Title
The NaBu Effect on Menstruation in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Menstruating regularly or irregularly
- Experiencing menstrual symptoms with an average baseline symptom score of at least 3 on a scale of 0 to 10 for at least one symptom during the initial pre-study rating period
You will not qualify if you...
- Pregnant or breastfeeding patient, attempting or anticipating pregnancy
- History of bloating or sensitive gut requiring lower fiber levels
- Known lactose intolerance, FODMAP intolerances, or small intestinal bacterial overgrowth (SIBO)
- Need for daily antacids during the study
- Known or suspected chronic hypertension
- Post-menopausal patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northwestern University - Northwestern Medicine, Lavin Family Pavilion
Chicago, Illinois, United States, 60611
Actively Recruiting
Research Team
J
juan A avitia, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here